Revive Rx recalls

Revive Rx has 3 recalls on record with the FDA and USDA, the earliest in 2022 and the latest reported on 5 Jun 2024. 2 are still ongoing. The most frequent reason is sterility.

Total recalls3since 2022

Last 12 months0reported

Class I267% of total

Ongoing2latest 5 Jun 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 2 67%Class II 1 33%Class III 0 0%

Why revive rx is recalled

Sterility3100%

Product types

Diabetes Medication267%
Injectable & IV Drugs133%

By year

2024133%
2023133%
2022133%

Ongoing revive rx recalls

2 active

Reported	Class	Recall	Company	Reason	Where
5 Jun 2024Drug	CLASS I	Tirzepatide 10 mg/ Sterile Solution Multi-dose vial recalled	Revive Rx	Sterility	Nationwide
31 May 2023Drug	CLASS II	Tirzepatide 10 mg/ Sterile Solution- Vial recalled by Revive Rx	Revive Rx	Sterility	Nationwide

All revive rx recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
5 Jun 2024Drug	CLASS I	Tirzepatide 10 mg/ Sterile Solution Multi-dose vial recalled	Revive Rx	Sterility	Nationwide
31 May 2023Drug	CLASS II	Tirzepatide 10 mg/ Sterile Solution- Vial recalled by Revive Rx	Revive Rx	Sterility	Nationwide
23 Feb 2022Drug	CLASS I	HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj. recalled	Revive Rx	Sterility	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.